Target intelligence / Profile preview

Chemerin chemokine-like receptor 2 (CMKLR2)

Target
CMKLR2
Molecular classification
G protein-coupled receptor, Receptor, Atypical chemokine receptor
01

Overview

Chemerin chemokine-like receptor 2 (CMKLR2, also known as CCRL2) is an atypical seven-transmembrane G protein-coupled receptor that binds the chemoattractant protein chemerin at its N-terminus but does not trigger canonical intracellular signaling or cell migration typically associated with GPCRs[1][3][5]. Unlike the functional signaling chemerin receptor CMKLR1, CCRL2 primarily serves as a non-signaling cell-surface anchoring protein that presents chemerin to other chemerin-responsive cells, especially at barrier tissues such as endothelial cells[1]. This receptor does not appreciably internalize or scavenge its ligand under physiological conditions and is believed to fine-tune immune responses by regulating chemerin’s local availability and presentation. Although implicated in the modulation of inflammation and immune cell trafficking, CCRL2 is currently viewed as a non-classical, non-signaling receptor, with disease roles and therapeutic targeting still under investigation[1][5].

Other names
C-C chemokine receptor-like 2CCRL2ChemR23-like 2CML2
02

Mechanism of action

not applicable; CCRL2/CMKLR2 binds chemerin but does not activate classical G protein-dependent signaling or internalization, so no known drug-mediated mechanism

03

Biological functions

Ligand binding (chemerin)Immune response modulationChemoattractant presentation (acts as a non-signaling chemerin-anchoring protein)
04

Disease associations

InflammationImmune disordersCancer (possible role suggested, but not fully established)
05

Safety considerations

potential for modulating immune cell trafficking and inflammation, but therapeutic challenges are not well characterized due to lack of signaling activity
06

Biomarkers

chemerin/CCRL2 axis may be explored as a biomarker for inflammatory status or immune cell trafficking, but not yet validated

Beyond the preview

Go deeper on Chemerin chemokine-like receptor 2 (CMKLR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemerin chemokine-like receptor 2 (CMKLR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call